Literature DB >> 33811364

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.

Vanitha Sampath1, Grace Rabinowitz1, Mihir Shah1, Surabhi Jain1, Zuzana Diamant2,3,4,5, Milos Jesenak6, Ronald Rabin7, Stefan Vieths8, Ioana Agache9, Mübeccel Akdis10, Domingo Barber11,12, Heimo Breiteneder13, Sharon Chinthrajah1,14, Tomas Chivato15, William Collins1,16, Thomas Eiwegger17,18,19, Katharine Fast1, Wytske Fokkens20, Robyn E O'Hehir21, Markus Ollert22,23, Liam O'Mahony24, Oscar Palomares25, Oliver Pfaar26, Carmen Riggioni27,28, Mohamed H Shamji29,30, Milena Sokolowska10, Maria Jose Torres31, Claudia Traidl-Hoffmann32,33, Menno van Zelm34,35, De Yun Wang36, Luo Zhang37, Cezmi A Akdis10, Kari C Nadeau1,14.   

Abstract

Vaccines are essential public health tools with a favorable safety profile and prophylactic effectiveness that have historically played significant roles in reducing infectious disease burden in populations, when the majority of individuals are vaccinated. The COVID-19 vaccines are expected to have similar positive impacts on health across the globe. While serious allergic reactions to vaccines are rare, their underlying mechanisms and implications for clinical management should be considered to provide individuals with the safest care possible. In this review, we provide an overview of different types of allergic adverse reactions that can potentially occur after vaccination and individual vaccine components capable of causing the allergic adverse reactions. We present the incidence of allergic adverse reactions during clinical studies and through post-authorization and post-marketing surveillance and provide plausible causes of these reactions based on potential allergenic components present in several common vaccines. Additionally, we review implications for individual diagnosis and management and vaccine manufacturing overall. Finally, we suggest areas for future research.
© 2021 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; allergy; anaphylaxis; vaccine

Year:  2021        PMID: 33811364     DOI: 10.1111/all.14840

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  25 in total

1.  Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.

Authors:  Eli Magen; Avi Yakov; Ilan Green; Ariel Israel; Shlomo Vinker; Eugene Merzon
Journal:  Allergy Asthma Proc       Date:  2022-01-01       Impact factor: 2.587

Review 2.  Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.

Authors:  Shuen-Iu Hung; Ivan Arni C Preclaro; Wen-Hung Chung; Chuang-Wei Wang
Journal:  Biomedicines       Date:  2022-05-28

Review 3.  Advances and highlights in biomarkers of allergic diseases.

Authors:  Ismail Ogulur; Yagiz Pat; Ozge Ardicli; Elena Barletta; Lacin Cevhertas; Ruben Fernandez-Santamaria; Mengting Huang; Manal Bel Imam; Jana Koch; Siyuan Ma; Debbie J Maurer; Yasutaka Mitamura; Yaqi Peng; Urszula Radzikowska; Arturo O Rinaldi; Juan Rodriguez-Coira; Pattraporn Satitsuksanoa; Stephan R Schneider; Alexandra Wallimann; Damir Zhakparov; Reihane Ziadlou; Marie-Charlotte Brüggen; Willem van de Veen; Milena Sokolowska; Katja Baerenfaller; Luo Zhang; Mubeccel Akdis; Cezmi A Akdis
Journal:  Allergy       Date:  2021-09-27       Impact factor: 14.710

4.  Recent advances and developments in COVID-19 in the context of allergic diseases.

Authors:  Mei Ding; Xiang Dong; Yuan-Li Sun; Milena Sokolowska; Mübeccel Akdis; Willem van de Veen; Ahmet Kursat Azkur; Dilek Azkur; Cezmi A Akdis; Ya-Dong Gao
Journal:  Clin Transl Allergy       Date:  2021-09       Impact factor: 5.657

5.  CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience.

Authors:  Reyhan Gumusburun; Ceyda Tunakan Dalgıc; Emine Nihal Mete Gokmen; Aytul Zerrin Sin
Journal:  Int Arch Allergy Immunol       Date:  2022-04-22       Impact factor: 3.767

6.  Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.

Authors:  Christopher Michael Warren; Theo Thomas Snow; Alexandra S Lee; Mihir Mukesh Shah; Anja Heider; Andra Blomkalns; Brooke Betts; Anthony S Buzzanco; Joseph Gonzalez; R Sharon Chinthrajah; Evan Do; Iris Chang; Diane Dunham; Grace Lee; Ruth O'Hara; Helen Park; Mohamed H Shamji; Lisa Schilling; Sayantani B Sindher; Deepak Sisodiya; Eric Smith; Mindy Tsai; Stephen J Galli; Cezmi Akdis; Kari C Nadeau
Journal:  JAMA Netw Open       Date:  2021-09-01

7.  First Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.

Authors:  Anna R Wolfson; Lacey B Robinson; Lily Li; Aubree E McMahon; Amelia S Cogan; Xiaoqing Fu; Paige Wickner; Upeka Samarakoon; Rebecca R Saff; Kimberly G Blumenthal; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06-21

Review 8.  SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center.

Authors:  Luciana Kase Tanno; Frédéric Berard; Etienne Beaudoin; Alain Didier; Pascal Demoly
Journal:  Vaccines (Basel)       Date:  2021-05-27

9.  Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following Immunization.

Authors:  Ana Lilia Peralta-Amaro; Melina Ivone Tejada-Ruiz; Karen Lilian Rivera-Alvarado; Orestes de Jesús Cobos-Quevedo; Patricia Romero-Hernández; Wiliams Macías-Arroyo; Alberto Avendaño-Ponce; Jorge Hurtado-Díaz; Olga Vera-Lastra; Abihai Lucas-Hernández
Journal:  Vaccines (Basel)       Date:  2022-01-16

Review 10.  A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.

Authors:  Domenico Galati; Serena Zanotta; Ludovica Capitelli; Marialuisa Bocchino
Journal:  Allergy       Date:  2021-07-24       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.